AgelessRx Research
LDN and NAD+ for Long COVID Fatigue: AgelessRx Trial Findings
Low Dose Naltrexone and NAD+ were tested together for Long COVID fatigue in our trial. Learn what the results showed and why the combination worked.
Acarbose Longevity Research: AgelessRx Trial Data
Our Research Team tracked Acarbose as a longevity intervention in a pilot trial. See biomarker findings, glucose data, and tolerability results.
Microdosing GLP-1 for Longevity: What Our Trial Is Studying
Explore how Microdosing Semaglutide may support metabolic health, inflammation, and longevity, including what our GLP-1 trial is studying.
XPRIZE Healthspan Update: Inside AgelessRx’s Longevity Clinical Trial
AgelessRx shares early XPRIZE Healthspan semifinal results and what they suggest about the future of personalized longevity medicine.
Inside the AgelessRx XPRIZE Trial
AgelessRx is an XPRIZE Healthspan semifinalist! Learn more about the AgelessRx XPRIZE trial and what this means for the future of aging.
AgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global Competition
AgelessRx is a Semi-Finalist in the landmark XPRIZE Healthspan competition, a milestone that may propel longevity solutions to the spotlight.
Could LDN and NAD+ Offer Hope for Long COVID?
Our experts launched a study to determine the effects of Low Dose Naltrexone and NAD+ on Long COVID. The results could move us closer to…
AgelessRx Donates to Support Biology of Aging Research
Learn about AgelessRx's gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.
PEARL Webinar Series: A Must-Watch Outlining Our Clinical Study
Check out this video webinar series about a new AgelessRx sponsored study on the use of Rapamycin in longevity treatment.
PEARL and Post-COVID Research Updates
AgelessRx is fully committed to longevity research. Check out a quick update on our two ongoing research projects, PEARL and Post-COVID.
A Quick Update on PEARL, AgelessRx’s Upcoming Clinical Trial
AgelessRx has started recruiting participants to our clinical trial PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity).
AgelessRx Launches Pilot Post-COVID Clinical Trial
Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.